Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yesiboli Tasiheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5088852312, A5092272548. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2022: 2 papers · 2023: 3 papers · 2024: 4 papers · 2025: none · 2026: 1 paper

Papers 10

  1. TCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer. Co-author DOI 10.1007/s10238-026-02109-3↗
  2. Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00262-024-03648-y↗
  3. DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer. Co-author DOI 10.1007/s00262-024-03786-3↗
  4. BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer. Co-author DOI 10.1016/j.bbadis.2024.167346↗
  5. Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid applic… Co-author DOI 10.1016/j.canlet.2024.216741↗
  6. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. Co-author DOI 10.1136/jitc-2023-006698↗
  7. Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures. Co-author DOI 10.3390/cancers15030828↗
  8. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol30020126↗
  9. Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41389-022-00411-9↗
  10. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2022/7353572↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuan Lin · 9 shared papers, 2022–2024 · strength 1.52
  2. Zhengjie Dai · 9 shared papers, 2022–2024 · strength 1.52
  3. Xianjun Yu · 9 shared papers, 2022–2024 · strength 1.52
  4. Yusheng Chen · 8 shared papers, 2022–2024 · strength 1.36
  5. Xuan Zou · 8 shared papers, 2022–2024 · strength 1.33
  6. Mingjian Ma · 7 shared papers, 2023–2024 · strength 1.25
  7. He Cheng · 6 shared papers, 2022–2024 · strength 0.97
  8. Xu Wang · 6 shared papers, 2022–2024 · strength 0.94
  9. He Cheng · 3 shared papers, 2024–2026 · strength 0.77
  10. Chen Liu · 5 shared papers, 2022–2024 · strength 0.76
  11. Chen Liu · 3 shared papers, 2023–2024 · strength 0.55
  12. Yu Yan · 3 shared papers, 2023–2024 · strength 0.51
  13. Yitao Gong · 2 shared papers, 2022 · strength 0.27
  14. Yunzhen Qian · 2 shared papers, 2022 · strength 0.27
  15. Guopei Luo · 2 shared papers, 2022 · strength 0.27
  16. Chen Liu · 1 shared paper, 2024 · strength 0.20
  17. Jia Dong · 1 shared paper, 2024 · strength 0.18
  18. Yusheng Chen · 1 shared paper, 2023 · strength 0.16
  19. Cheng He · 1 shared paper, 2023 · strength 0.16
  20. Fei Ding · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.